
|Articles|January 10, 2005
New drug treats overactive bladder without drying mouth
Overactive bladder (OAB) affects approximately 17 million to 20 million people in the United States, yet few realize that it is a treatable condition. Many people believe that it is a natural part of the aging process and are embarrassed to discuss it. It is estimated that costs related to OAB were nearly $14 billion in this country in 2000, similar to that of gynecological and breast cancers, osteoporosis, or arthritis.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025
2
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
3
The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025
4
Why Pharmacists Need to Put More Emphasis on Supplement Education | NCPA 2025
5